Turner necrosis factor alpha promoter polymorphism at position-238 is associated with chronic active hepatitis C infection

被引:0
|
作者
Höhler, T
Kruger, A
Gerken, G
Schneider, PM
zum Büschenfelde, KHM
Rittner, C
机构
[1] Univ Mainz, Dept Internal Med 1, D-6500 Mainz, Germany
[2] Univ Mainz, Inst Legal Med, D-6500 Mainz, Germany
关键词
major histocompatibility complex; viral clearance; cytokines; linkage disequilibrium;
D O I
10.1002/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tumor necrosis factor alpha (TNF-alpha) is involved in the pathogenesis of chronic hepatitis C virus infection. The gene for TNF-alpha is encoded in the major histocompatibility locus (MHC). Two polymorphisms at positions -308 and -238 in the TNF-alpha promoter region might influence TNF-alpha expression. These promoter polymorphisms have been linked previously to a number of infectious diseases. TNF-alpha promoter polymorphisms at positions -238 and -308 were studied by DNA sequencing and sequence-specific oligonucleotide hybridization in 82 individuals with chronic hepatitis C and 99 control subjects. Subjects had been HLA class I and class Il typed in a previous study. The frequency of the TNF238.2 promoter allele was significantly higher in the hepatitis C group (18.7%) compared to the controls (3.5%; P < 0.0001; pcorr < 0.009). No significant differences in the frequency of the TNF308.2 allele were observed between patients and controls. The increased frequency of the TNF238.2 allele could not be explained by linkage disequilibrium to HLA-B or -DR genes. These findings show an association between the TNF238.2 promoter variant and chronic active hepatitis C. They suggest that this polymorphism or a linked gene may be a host factor contributing to the development of chronic active hepatitis C. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 50 条
  • [1] Tumor Necrosis Factor-Alpha Polymorphism at Position-238 in Preeclampsia
    Naderi, Mohammad
    Yaghootkar, Hanieh
    Tara, Fatemeh
    Afshari, Jalil Tavakkol
    Hosseini, Reza Farid
    Mobarhan, Majid Ghayour
    Moghadam, Abbas Shapouri
    Mirteimouri, Masoumeh
    Tara, Seyedeh Maryam
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (01)
  • [2] Polymorphism at position-238 of the tumor necrosis factor alpha and rheumatoid arthritis: Prognosis and pharmacogenetics-interim analysis
    Cavaleiro, J
    Fonseca, JE
    Sobral, M
    Mourao, AF
    Cruz, M
    Carvalho, T
    Canhao, H
    Costa, MM
    Castelao, W
    Macieira, C
    Santos, SA
    Laudin, E
    Costa, RP
    da Silva, JC
    da Silva, JAP
    Queiroz, MV
    Branco, J
    Carmo-Fonseca, M
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 177 - 177
  • [3] A tumour necrosis factor-alpha (TNF-α) promoter polymorphism is associated with chronic hepatitis B infection
    Höhler, T
    Kruger, A
    Gerken, G
    Schneider, PM
    Zum Büschenfelde, KHM
    Rittner, C
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 111 (03): : 579 - 582
  • [4] Associations of tumour necrosis factor alpha promoter polymorphisms at position-308 and -238 with clinical characteristics of chronic hepatitis C
    Dai, C-Y.
    Chuang, W-L.
    Lee, L-P.
    Chen, S-C.
    Hou, N-J.
    Lin, Z-Y.
    Hsieh, M-Y.
    Hsieh, M-Y.
    Wang, L-Y.
    Chang, W-Y.
    Yu, M-L.
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (11) : 770 - 774
  • [5] Tumour necrosis factor alpha promoter polymorphism at position-308 is not associated with actinic prurigo
    Grabczynska, SA
    Carey, BS
    McGregor, JM
    Hawk, JLM
    Vaughan, RW
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2001, 26 (08) : 700 - 704
  • [6] Tumor necrosis factor α promoter polymorphisms at position -: 308 in Taiwanese chronic hepatitis C patients treated with interferon-alpha
    Yu, ML
    Dai, CY
    Chiu, CC
    Lee, LP
    Lin, ZY
    Chen, SC
    Hsieh, MY
    Wang, LY
    Chen, CJ
    Chuang, WL
    Chang, WY
    ANTIVIRAL RESEARCH, 2003, 59 (01) : 35 - 40
  • [7] Tumour necrosis factor alpha gene -238G/A promoter polymorphism associated with more rapid onset of lipodystrophy
    Nolan, D
    Moore, C
    Castley, A
    Sayer, D
    Mamotte, C
    John, M
    James, I
    Mallal, S
    ANTIVIRAL THERAPY, 2002, 7 (03) : L17 - L17
  • [8] Tumor necrosis factor-α promoter polymorphism at position-308 predicts response to combination therapy in hepatitis C virus infection
    Dai, CY
    Chuang, WL
    Chang, WY
    Chen, SC
    Lee, LP
    Hsieh, MY
    Hou, NJ
    Lin, ZY
    Huang, JF
    Hsieh, MY
    Wang, LY
    Yu, ML
    JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (01): : 98 - 101
  • [9] The human tumor necrosis factor alpha (TNF)-238 promoter polymorphism in patients with ankylosing spondylitis
    Kaijzel, EL
    Brinkman, BMN
    Smith, L
    van Krugten, MV
    Huizinga, TWJ
    Verjans, GMGM
    Breedveld, FC
    Verweij, CL
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S287 - S287
  • [10] The relation of tumor necrosis factor alpha gene promoter polymorphism and outcome of interferon therapy for hepatitis C
    Chiu, CC
    Yu, M
    Chuang, W
    Lin, Z
    Chen, S
    Hsieh, M
    Wang, L
    Tsai, J
    Chang, W
    JOURNAL OF HEPATOLOGY, 2001, 34 : 157 - 157